OPXS Optex Systems Holdings Inc (QB)

SCHEDULE 13D

*Henry Investment Trust, L.P. is the sole general partner of each of Henry Partners, L.P. and Matthew Partners, L.P. Reference is made to Item 2 to this Schedule 13D.

2

*Henry Investment Trust, L.P. is the sole general partner of each of Henry Partners, L.P. and Matthew Partners, L.P. Reference is made to Item 2 to this Schedule 13D.

3

* Henry Investment Trust, L.P. is the sole general partner of each of Henry Partners, L.P. and Matthew Partners, L.P. See Item 2 of this Schedule 13D.

4

*NOTE: David W. Wright is the President of Canine Partners, LLC, which is the sole general partner of Henry Investment Trust, L.P. Henry Investment Trust, L.P. is the sole general partner of each of Henry Partners, L.P. and Matthew Partners, L.P.

5

Item 1.    Security and Issuer.

This statement relates to shares of the common stock, $.001 par value per share (the “Shares”), of Optex Systems Holdings, Inc. (the “Issuer”). The principal executive offices of the Issuer are located at 1420 Presidential Drive, Richardson, TX 75081.

Item 2.    Identity and Background.

(a)—(c)

This Statement is filed by Henry Partners, L.P. (“Henry”), Matthew Partners, L.P. (“Matthew”), Henry Investment Trust, L.P. (“HIT”) and David W. Wright. Henry and Matthew are private investment funds. HIT is the sole General Partner of each of Henry and Matthew. Mr. Wright is the investment manager of each of Henry and Matthew and is the President of Canine Partners, LLC (“Canine”), the General Partner of HIT. Investment decisions made on behalf of Henry and Matthew are made primarily through their General Partner and Mr. Wright. Each of the foregoing persons is sometimes referred to in this Schedule 13D as a “Reporting Person” and collectively as the “Reporting Persons.” The principal business address of each Reporting Person is 255 South 17th Street, Suite 1102, Philadelphia, PA 19103.

(d) None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) None of the Reporting Persons has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) Henry and Matthew are Delaware limited partnerships. HIT is a Pennsylvania limited partnership. Canine is a Pennsylvania limited liability company, and David W. Wright is a citizen of the United States.

Item 3.    Source and Amount of Funds or Other Consideration.

The aggregate purchase price of the 445,000 Shares owned by Henry is $739,323.90, the aggregate purchase price of the 350,000 Shares owned by Matthew is $582,414.33 and the aggregate purchase price of the 35,100 Shares owned by Mr. Wright is $61,147.50. Shares owned by Henry and Matthew were acquired with the funds of each respective partnership. Shares owned by Mr. Wright were acquired with personal funds of Mr. Wright.

Item 4.    Purpose of the Transaction.

The Reporting Persons purchased the Shares based on the Reporting Persons’ belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, the availability of Shares at prices that would make the purchase of additional Shares desirable, or the market price at which Shares are then currently trading that would make the sale of Shares desirable (in either case, including market prices that may exist as a result of this filing or other filings by the Reporting Persons), the Reporting Persons may increase or decrease their position in the

6

Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a)—(j) of Item 4 of Schedule 13D, except as set forth herein or such as would occur upon completion of any of the actions discussed herein.

The Reporting Persons are concerned about the Issuer’s corporate governance and executive compensation practices and are converting their filing to Schedule 13D in order to have more direct conversations with the Issuer, other stockholders and interested third parties about their concerns. Such conversations have included and could include, but may not be limited to, discussing changes to the composition of the Issuer’s Board of Directors. Concurrently with the filing of this Schedule 13D, the Reporting Persons are sending to the Board of Directors of the Issuer a letter raising their concerns about the Issuer’s corporate governance and executive compensation practices, the effects of those practices on the Issuer and the market for its securities and their desire to discuss those views with management and the Board of Directors, including how they, along with other large stockholders, can immediately work together with the Issuer to improve board structure and governance practices. These improvements may include appointing new directors selected and supported by the Issuer’s largest stockholders to serve on the Board of Directors. It is the desire of the Reporting Persons that management and the Board of Directors promptly engage with the Reporting Persons and the other largest stockholders of the Issuer regarding these matters.

Each of the Reporting Persons intends to review its investment in the Issuer on a continuing basis and to engage in discussions with management, other stockholders and the Board of Directors of the Issuer concerning the business, operations, corporate governance and future plans of the Issuer. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general political, economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation,

Item 5.    Interest in Securities of the Issuer.

(a)-(b)

The aggregate percentage of Shares reported owned by each person named herein is based upon 8,436,422 Shares outstanding, which is the total number of Shares outstanding as reported in the Issuer’s quarterly report on Form 10-Q for the quarter ended June 30, 2019. As of September 7, 2019,

7

Henry beneficially owned 445,000 Shares, constituting approximately 5.3% of the Shares outstanding, Matthew beneficially owned 350,000 Shares, constituting approximately 4.1% of the Shares outstanding, and Mr. Wright beneficially owned 35,100 Shares for an aggregate ownership of Henry, Matthew and Mr. Wright of 830,100 Shares, constituting 9.8% of the Shares outstanding. Mr. Wright, as President of the sole general partner of HIT, which is the sole general partner of each of Henry and Matthew, has the authority to vote and dispose of such Shares.

Each of Mr. Wright, Canine Partners, LLC and Henry Investment Trust, L.P. disclaims beneficial ownership of the Shares reported, except to the extend to their respective pecuniary interest in such Shares.

(c) None of the Reporting Persons effected any transactions in the Issuer’s Shares during the past sixty days.

(d) No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such Shares.

(e) Not applicable.

None of the Reporting Persons currently own or have owned within the past 60 days any of the Issuer’s outstanding warrants.

Item 6.    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Other than as described herein, there are no contracts, arrangements or understandings among the persons named in Item 2, or among the persons named in Item 2 and any other person, with respect to the securities of the Issuer.

Item 7.    Material To Be Filed As Exhibits.

1. Joint Filing Agreement.

8

SIGNATURE

After reasonable inquiry and to the best of the undersigneds’ knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

9